- Home
- AVTR vs BAX Comparison
AVTR vs BAX Comparison
Compare AVTR & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVTR | BAX |
|---|---|---|
| Founded | 1904 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 9.4B |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | AVTR | BAX |
|---|---|---|
| Price | $11.51 | $18.26 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 10 |
| Target Price | $15.31 | ★ $25.67 |
| AVG Volume (30 Days) | ★ 8.3M | 8.3M |
| Earning Date | 10-29-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 0.22% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $6,575,200,000.00 | ★ $11,023,000,000.00 |
| Revenue This Year | N/A | $5.20 |
| Revenue Next Year | $0.17 | $2.02 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 3.90 |
| 52 Week Low | $10.62 | $17.40 |
| 52 Week High | $23.32 | $37.74 |
Technical Indicators
Market Signals| Indicator | AVTR | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 48.41 | 42.10 |
| Support Level | $10.86 | $18.33 |
| Resistance Level | $11.89 | $19.17 |
| Average True Range (ATR) | 0.36 | 0.48 |
| MACD | 0.03 | 0.12 |
| Stochastic Oscillator | 70.47 | 51.53 |
Price Performance
Historical ComparisonAbout AVTR Avantor Inc.
Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.